Genertec Universal Medical Group Co Stock | 2666.HK | HK0000255361 | A14V3L

Date	Genertec Universal Medical Group Co Price
11/14/2024	4.50 undefined
11/13/2024	4.50 undefined
11/12/2024	4.56 undefined
11/11/2024	4.64 undefined
11/8/2024	4.68 undefined
11/7/2024	4.71 undefined
11/6/2024	4.66 undefined
11/5/2024	4.63 undefined
11/4/2024	4.56 undefined
11/1/2024	4.55 undefined
10/31/2024	4.47 undefined
10/30/2024	4.43 undefined
10/29/2024	4.50 undefined
10/28/2024	4.52 undefined
10/25/2024	4.50 undefined
10/24/2024	4.52 undefined
10/23/2024	4.63 undefined
10/22/2024	4.59 undefined
10/21/2024	4.58 undefined
10/18/2024	4.60 undefined
10/17/2024	4.43 undefined

Date	Genertec Universal Medical Group Co Revenue	Genertec Universal Medical Group Co EBIT	Genertec Universal Medical Group Co Net Income
2026e	11.45 B undefined	3.58 B undefined	2.35 B undefined
2025e	15.97 B undefined	3.23 B undefined	2.23 B undefined
2024e	14.58 B undefined	3 B undefined	2.08 B undefined
2023	13.65 B undefined	2.53 B undefined	2.02 B undefined
2022	12.07 B undefined	2.51 B undefined	1.89 B undefined
2021	9.91 B undefined	2.93 B undefined	1.84 B undefined
2020	8.52 B undefined	2.58 B undefined	1.65 B undefined
2019	6.82 B undefined	2.33 B undefined	1.49 B undefined
2018	4.3 B undefined	1.89 B undefined	1.35 B undefined
2017	3.42 B undefined	1.54 B undefined	1.15 B undefined
2016	2.7 B undefined	1.19 B undefined	872.31 M undefined
2015	2.19 B undefined	845.09 M undefined	658.53 M undefined
2014	1.55 B undefined	604.52 M undefined	456.64 M undefined
2013	981.5 M undefined	364.3 M undefined	312.7 M undefined
2012	593.3 M undefined	232.8 M undefined	177.7 M undefined

	Revenue	EBIT	Net Income
2012	593.3 M CNY	232.8 M CNY	177.7 M CNY
2013	981.5 M CNY	364.3 M CNY	312.7 M CNY
2014	1.55 B CNY	604.52 M CNY	456.64 M CNY
2015	2.19 B CNY	845.09 M CNY	658.53 M CNY
2016	2.7 B CNY	1.19 B CNY	872.31 M CNY
2017	3.42 B CNY	1.54 B CNY	1.15 B CNY
2018	4.3 B CNY	1.89 B CNY	1.35 B CNY
2019	6.82 B CNY	2.33 B CNY	1.49 B CNY
2020	8.52 B CNY	2.58 B CNY	1.65 B CNY
2021	9.91 B CNY	2.93 B CNY	1.84 B CNY
2022	12.07 B CNY	2.51 B CNY	1.89 B CNY
2023	13.65 B CNY	2.53 B CNY	2.02 B CNY
2024e	14.58 B CNY	3 B CNY	2.08 B CNY
2025e	15.97 B CNY	3.23 B CNY	2.23 B CNY
2026e	11.45 B CNY	3.58 B CNY	2.35 B CNY

2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e
0.59	0.98	1.55	2.19	2.7	3.42	4.3	6.82	8.52	9.91	12.07	13.65	14.58	15.97	11.45
-	65.43	58.21	41.30	23.12	26.59	25.69	58.64	25.03	16.35	21.78	13.06	6.81	9.51	-28.28
65.43	64.42	60.12	59.64	64.22	63.60	60.31	46.65	41.70	42.35	37.22	33.49	31.35	28.63	39.91
0.39	0.63	0.93	1.31	1.73	2.17	2.59	3.18	3.55	4.2	4.49	4.57	0	0	0
0.18	0.31	0.46	0.66	0.87	1.15	1.35	1.49	1.65	1.84	1.89	2.02	2.08	2.23	2.35
-	76.27	46.15	44.30	32.52	31.65	17.77	10.06	10.69	11.41	2.89	6.99	2.82	7.32	5.38
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
0.47	0.61	0.9	1.48	1.72	1.72	1.72	1.72	1.72	2.04	2.08	2.08	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

0.31	0.32	0.45	1.87	1.27	1.75	2.17	3.39	2.04	2.4	2.86	2.91
1.54	2.58	4.17	5.92	7.01	9.18	11.83	16.12	0	0	-0.03	-0.03
0.01	0.02	0.03	0.03	0.03	0.02	0.05	0.3	0	0	24.02	26.27
4	3	3.12	2.64	2.05	21.05	40.54	156.73	198.03	272.28	388.05	431.14
0.11	0.25	0.1	0.14	0.67	0.95	0.57	0.75	0.73	1.32	0.92	1.11
1.97	3.17	4.76	7.96	8.98	11.93	14.66	20.71	2.97	3.99	28.16	30.7
0.06	0.1	0.09	0.09	0.1	0.09	0.27	2.81	3.11	3.33	4.98	5.55
0	0	20.96	64.92	64.92	43.96	0	449.01	460.11	846.77	760.95	777.65
3.72	6.98	11.47	15.41	19.75	25.39	31.84	33.41	35.53	39.52	41.39	41.54
0	0	0	0	0	0	0	0	58.6	46.18	79.17	161.27
0	0	0	0	0	9.21	9.21	69.91	69.91	102.25	102.25	286.54
0.13	0.2	0.04	0.13	0.07	0.28	0.47	0.4	0.45	1.08	1.51	1.33
3.92	7.28	11.63	15.69	19.99	25.81	32.6	37.14	39.68	44.92	48.82	49.65
5.88	10.45	16.39	23.66	28.96	37.73	47.26	57.85	42.65	48.92	76.98	80.34

0.78	0.78	1.58	4.33	4.33	4.33	4.33	4.33	4.33	5.3	5.3	5.3
0	0	0	0	0	0	0	0	0	0	0	0
0.08	0.39	0.85	1.52	2.22	3.11	4.11	5.19	6.39	7.73	8.61	10.37
0	0	0	0.03	0.03	0.03	1.61	1.62	1.7	1.74	1.74	1.68
0	0	0	0	0	0	0	0	0	0	0	0
0.86	1.17	2.43	5.88	6.57	7.47	10.05	11.14	12.42	14.76	15.64	17.35
0.31	0.24	0.85	0.09	0.19	0.26	0.48	1.29	0.87	1.14	2.27	2.87
30	57	120.89	220.34	224.3	295.64	487.44	614.58	557.41	720.5	758.52	910.39
0.19	0.29	0.26	0.2	0.47	0.64	0.51	1.87	2.04	2.9	2.63	3.75
0.24	0	0	0	0	0	2.15	2.58	2.32	0	2.52	6.6
2.13	3.41	4.18	7.63	6.28	10.96	10.2	12.41	17.53	14.75	18.28	15.94
2.89	3.99	5.41	8.15	7.17	12.16	13.83	18.76	23.32	19.51	26.46	30.07
2.1	5.26	8.47	9.46	14.97	17.8	22.73	25.02	22.4	29.43	29.46	28.61
0	0	0	0	0	0	0	0	9.18	0	0	0
0.05	0.03	0.07	0.17	0.25	0.3	0.45	0.63	0.83	4.12	1.34	1.3
2.14	5.29	8.55	9.63	15.22	18.1	23.17	25.65	23.24	33.55	30.8	29.9
5.03	9.28	13.96	17.78	22.39	30.26	37	44.41	46.55	53.06	57.26	59.98
5.88	10.45	16.39	23.66	28.96	37.73	47.05	55.55	58.98	67.82	72.9	77.33

2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
0.24	0.42	0.61	0.9	1.21	1.58	1.86	2.21	2.37	2.69	2.7
8	16	15	15	22	27	31	139	270	319	438
0	0	0	0	0	0	0	0	0	0	0
-2,050	-4,903	-5,431	-7,136	-4,657	-7,889	-9,320	-6,256	-5,655	-6,616	-3,741
0.21	0.35	0.69	0.9	1.05	1.21	1.7	2.08	2.05	2.21	2.66
0.13	0.32	0.8	0.87	0.84	1.2	1.37	1.93	1.89	1.69	1.98
58	108	167	187	361	533	544	626	680	709	705
-1.59	-4.12	-4.11	-5.32	-2.38	-5.07	-5.73	-1.82	-0.97	-1.4	2.06
-60	0	0	-28	-20	-18	-17	-208	-401	-385	-608
-60	0	0	-71	-459	-90	358	-87	-296	-664	-128
0	0	0	-43	-439	-71	375	120	104	-279	479
0	0	0	0	0	0	0	0	0	0	0
1.38	4.2	4.13	3.95	3.27	7.36	7.54	5.07	2.48	4.02	0.83
0.38	0	0	2.78	0	0	0	0	0	0.97	0
1.68	4.14	4.25	6.67	2.18	5.72	5.77	3.02	-0.03	2.39	-1.57
-77.00	-60.00	-608.00	-53.00	-903.00	-1,380.00	-1,427.00	-1,645.00	-2,058.00	-2,114.00	-1,810.00
0	0	-77	-8	-188	-254	-336	-407	-454	-482	-580
0.03	0.01	0.13	1.41	-0.59	0.48	0.42	1.21	-1.35	0.31	0.34
-1,653.4	-4,120	-4,111.46	-5,349.78	-2,401.85	-5,091.04	-5,746.29	-2,032.15	-1,373.12	-1,785.64	1,449.11
0	0	0	0	0	0	0	0	0	0	0

Genertec Universal Medical Group Co Gross margin	Genertec Universal Medical Group Co Profit margin	Genertec Universal Medical Group Co EBIT margin	Genertec Universal Medical Group Co Profit margin
2026e	33.49 %	31.23 %	20.51 %
2025e	33.49 %	20.22 %	13.96 %
2024e	33.49 %	20.55 %	14.25 %
2023	33.49 %	18.51 %	14.81 %
2022	37.23 %	20.79 %	15.64 %
2021	42.36 %	29.55 %	18.51 %
2020	41.71 %	30.33 %	19.33 %
2019	46.64 %	34.17 %	21.84 %
2018	60.31 %	44 %	31.47 %
2017	63.59 %	45.03 %	33.6 %
2016	64.24 %	44.05 %	32.3 %
2015	59.66 %	38.53 %	30.02 %
2014	60.1 %	38.93 %	29.41 %
2013	64.47 %	37.12 %	31.86 %
2012	65.48 %	39.24 %	29.95 %

	Gross margin	EBIT margin	Profit margin
2012	65.48 %	39.24 %	29.95 %
2013	64.47 %	37.12 %	31.86 %
2014	60.1 %	38.93 %	29.41 %
2015	59.66 %	38.53 %	30.02 %
2016	64.24 %	44.05 %	32.3 %
2017	63.59 %	45.03 %	33.6 %
2018	60.31 %	44 %	31.47 %
2019	46.64 %	34.17 %	21.84 %
2020	41.71 %	30.33 %	19.33 %
2021	42.36 %	29.55 %	18.51 %
2022	37.23 %	20.79 %	15.64 %
2023	33.49 %	18.51 %	14.81 %
2024e	33.49 %	20.55 %	14.25 %
2025e	33.49 %	20.22 %	13.96 %
2026e	33.49 %	31.23 %	20.51 %

Date	Genertec Universal Medical Group Co Sales per Share	Genertec Universal Medical Group Co EBIT per share	Genertec Universal Medical Group Co Earnings per Share
2026e	6.05 undefined	0 undefined	1.24 undefined
2025e	8.44 undefined	0 undefined	1.18 undefined
2024e	7.71 undefined	0 undefined	1.1 undefined
2023	6.55 undefined	1.21 undefined	0.97 undefined
2022	5.81 undefined	1.21 undefined	0.91 undefined
2021	4.87 undefined	1.44 undefined	0.9 undefined
2020	4.96 undefined	1.51 undefined	0.96 undefined
2019	3.97 undefined	1.36 undefined	0.87 undefined
2018	2.5 undefined	1.1 undefined	0.79 undefined
2017	1.99 undefined	0.9 undefined	0.67 undefined
2016	1.57 undefined	0.69 undefined	0.51 undefined
2015	1.48 undefined	0.57 undefined	0.44 undefined
2014	1.72 undefined	0.67 undefined	0.51 undefined
2013	1.6 undefined	0.59 undefined	0.51 undefined
2012	1.25 undefined	0.49 undefined	0.38 undefined

	Sales per Share	EBIT per share	Earnings per Share
2012	1.25 CNY	0.49 CNY	0.38 CNY
2013	1.6 CNY	0.59 CNY	0.51 CNY
2014	1.72 CNY	0.67 CNY	0.51 CNY
2015	1.48 CNY	0.57 CNY	0.44 CNY
2016	1.57 CNY	0.69 CNY	0.51 CNY
2017	1.99 CNY	0.9 CNY	0.67 CNY
2018	2.5 CNY	1.1 CNY	0.79 CNY
2019	3.97 CNY	1.36 CNY	0.87 CNY
2020	4.96 CNY	1.51 CNY	0.96 CNY
2021	4.87 CNY	1.44 CNY	0.9 CNY
2022	5.81 CNY	1.21 CNY	0.91 CNY
2023	6.55 CNY	1.21 CNY	0.97 CNY
2024e	7.71 CNY	0 CNY	1.1 CNY
2025e	8.44 CNY	0 CNY	1.18 CNY
2026e	6.05 CNY	0 CNY	1.24 CNY

	Number of stocks
2012	473.5 M Aktien
2013	613 M Aktien
2014	900.47 M Aktien
2015	1.48 B Aktien
2016	1.72 B Aktien
2017	1.72 B Aktien
2018	1.72 B Aktien
2019	1.72 B Aktien
2020	1.72 B Aktien
2021	2.04 B Aktien
2022	2.08 B Aktien
2023	2.08 B Aktien
2024e	2.08 B Aktien
2025e	2.08 B Aktien
2026e	2.08 B Aktien

Date	Genertec Universal Medical Group Co Dividend
2026e	0.37 undefined
2025e	0.37 undefined
2024e	0.37 undefined
2023	0.34 undefined
2022	0.36 undefined
2021	0.31 undefined
2020	0.29 undefined
2019	0.27 undefined
2018	0.24 undefined
2017	0.17 undefined
2016	0.13 undefined

	Dividend	Dividend (Estimate)
2012	0 CNY	0 CNY
2013	0 CNY	0 CNY
2014	0 CNY	0 CNY
2015	0 CNY	0 CNY
2016	0.13 CNY	0 CNY
2017	0.17 CNY	0 CNY
2018	0.24 CNY	0 CNY
2019	0.27 CNY	0 CNY
2020	0.29 CNY	0 CNY
2021	0.31 CNY	0 CNY
2022	0.36 CNY	0 CNY
2023	0.34 CNY	0 CNY
2024e	0 CNY	0.37 CNY
2025e	0 CNY	0.37 CNY
2026e	0 CNY	0.37 CNY

Date	Genertec Universal Medical Group Co Payout ratio
2026e	35.6 %
2025e	36.4 %
2024e	35.91 %
2023	34.48 %
2022	38.82 %
2021	34.42 %
2020	30.21 %
2019	31.13 %
2018	30.46 %
2017	25.4 %
2016	25.58 %
2015	34.48 %
2014	34.48 %
2013	34.48 %
2012	34.48 %

	Payout ratio
2012	34.48 %
2013	34.48 %
2014	34.48 %
2015	34.48 %
2016	25.58 %
2017	25.4 %
2018	30.46 %
2019	31.13 %
2020	30.21 %
2021	34.42 %
2022	38.82 %
2023	34.48 %
2024e	35.91 %
2025e	36.4 %
2026e	35.6 %

%	Name	Stocks	Change	Date
40.09760 %	China General Technology (Group) Holding Co., Ltd.	758,462,200	13,610,500	6/11/2024
7.91530 %	Meta Group Ltd.	149,721,081	-20,114,000	5/31/2024
2.90705 %	Hopson Development Holdings Ltd.	54,988,000	-16,000,000	5/31/2024
1.18416 %	The Vanguard Group, Inc.	22,398,902	180,000	9/30/2024
0.83059 %	BlackRock Institutional Trust Company, N.A.	15,711,000	55,000	9/30/2024
0.80680 %	Dimensional Fund Advisors, L.P.	15,261,000	0	9/30/2024
0.40271 %	Peng (Jiahong)	7,617,400	0	5/16/2024
0.29541 %	State Street Global Advisors (US)	5,587,736	88,000	9/30/2024
0.28384 %	Florida State Board of Administration	5,369,000	1,329,700	6/30/2024
0.27700 %	CITIC Capital Equity Investment (Tianjin) Co., Ltd.	5,239,500	-12,000,000	9/30/2024
0.24512 %	California State Teachers Retirement System	4,636,500	4,151,500	6/30/2023
0.18070 %	AllianceBernstein L.P.	3,418,000	0	8/31/2024
0.16019 %	Huisheng Fund Management Co., Ltd.	3,030,000	-1,419,500	6/30/2024
0.14541 %	American Century Investment Management, Inc.	2,750,500	0	7/31/2024
0.12738 %	HSBC JinTrust Fund Management Co., Ltd.	2,409,500	2,409,500	6/30/2024
0.12136 %	BlackRock Advisors (UK) Limited	2,295,500	26,000	9/30/2024
0.11720 %	E Fund Management Co. Ltd.	2,216,797	2,183,476	6/30/2024
0.10791 %	Union Investment Luxembourg S.A.	2,041,205	0	6/30/2024
0.07277 %	California Public Employees' Retirement System	1,376,500	-35,000	6/30/2023
0.07224 %	Dimensional Fund Advisors, Ltd.	1,366,500	0	9/30/2024
0.05554 %	Taikang Asset Management Co., Ltd.	1,050,500	1,050,500	6/30/2024
0.05131 %	China Asset Management Co., Ltd.	970,500	956,500	6/30/2024
0.03963 %	Fondsm¿glerselskabet Maj Invest A/S	749,579	81,620	8/31/2024
0.03919 %	Geode Capital Management, L.L.C.	741,313	-16,687	8/31/2024
0.03817 %	Maxwealth Fund Management Co., Ltd.	722,000	722,000	6/30/2024
0.03357 %	Nuveen LLC	635,000	0	7/31/2024
0.03193 %	Penghua Fund Management Co., Ltd.	604,000	511,500	6/30/2024
0.02727 %	Mackenzie Investments	515,890	-3,633	6/30/2024
0.02210 %	AXA Investment Managers UK Ltd.	418,000	-547,500	8/31/2024
0.02112 %	GF Fund Management Co., Ltd.	399,500	399,500	6/30/2024
0.01665 %	Guotai Asset Management Co., Ltd.	315,000	315,000	6/30/2024
0.01382 %	Ping An Fund Management Company Limited	261,500	261,500	6/30/2024
0.01332 %	State Street Global Advisors Ireland Limited	252,000	0	9/30/2024
0.01190 %	Northern Trust Investments, Inc.	225,000	0	9/30/2024
0.01110 %	Norges Bank Investment Management (NBIM)	210,022	19	6/30/2024
0.00999 %	Yinhua Fund Management Co., Ltd.	189,000	189,000	6/30/2024
0.00800 %	DFA Australia Ltd.	151,395	-77	8/31/2024
0.00727 %	Allianz Global Investors GmbH	137,500	0	3/31/2024
0.00615 %	Macquarie Investment Management Global Ltd.	116,361	1,428	7/31/2024
0.00608 %	Vanguard Global Advisers LLC	115,000	0	9/30/2024
0.00529 %	Topsperity Fund Management Co., Ltd.	100,000	100,000	6/30/2024
0.00400 %	Vanguard Investments Australia Ltd.	75,673	-12,666	6/30/2024
0.00349 %	Broad Asset Management Co., Ltd	66,000	66,000	6/30/2024
0.00280 %	Finlabo SIM S.p. A.	53,000	0	9/30/2024
0.00167 %	Avantis Investors	31,500	-326,000	6/30/2024
0.00159 %	Chan (Kai Kong)	30,000	0	12/31/2023
0.00156 %	Mellon Investments Corporation	29,500	0	8/31/2024
0.00088 %	MLC Asset Management	16,656	12,821	3/31/2024
0.00077 %	Dimensional Fund Advisors Canada ULC	14,500	0	5/31/2024
0.00057 %	Arrowstreet Capital, Limited Partnership	10,778	10,778	6/30/2024
0.00032 %	BlackRock (Luxembourg) S.A.	6,000	6,000	6/30/2024
0.00032 %	Fullgoal Fund Management Co., Ltd.	6,000	-1,968,000	6/30/2024
0.00003 %	China Merchants Fund Management Co. Ltd.	500	500	6/30/2024
0.00002 %	MLC Investments Limited	386	386	2/29/2024
0 %	Man Investments Inc	0	-1,409	8/31/2024
0 %	JPMorgan Asset Management (China) Company Limited.	0	-726,500	6/30/2024
0 %	Everbright PGIM Fund Management Co., Ltd.	0	-1,348,000	12/31/2023
0 %	Man Investments, Ltd.	0	-702	8/31/2024
0 %	Russell Investments Japan Co., Ltd.	0	-49,556	8/31/2023
0 %	SEI Investments Management Corporation	0	-564,672	9/30/2024
0 %	Causeway Capital Management LLC	0	-981,500	6/30/2023
0 %	First Trust Advisors L.P.	0	-3,172,424	4/30/2024
0 %	Boston Partners	0	-150,500	5/31/2024
0 %	Thrivent Asset Management, LLC	0	-310,500	12/31/2023
0 %	Numeric Investors LLC	0	-212,415	7/31/2024
0 %	Everbright Securities Asset Management Co., Ltd.	0	-288,000	12/31/2023

What values and corporate philosophy does Genertec Universal Medical Group Co represent?

Genertec Universal Medical Group Co Ltd embraces a set of core values and corporate philosophy that defines its operations. As a leading medical services company, Genertec Universal Medical Group Co Ltd prioritizes excellence, patient-centered care, and innovation in the healthcare industry. With a focus on providing high-quality medical services, the company upholds integrity, professionalism, and compassion in all its endeavors. By combining cutting-edge technology and advanced medical expertise, Genertec Universal Medical Group Co Ltd aims to enhance patient outcomes and contribute to the overall advancement of healthcare.

In which countries and regions is Genertec Universal Medical Group Co primarily present?

Genertec Universal Medical Group Co Ltd is primarily present in China.

What significant milestones has the company Genertec Universal Medical Group Co achieved?

Some significant milestones achieved by Genertec Universal Medical Group Co Ltd include successful partnerships with leading healthcare organizations, expansion into international markets, and the development of innovative medical technologies. The company has established strategic alliances with renowned medical institutions, enhancing its research and development capabilities. Genertec Universal Medical Group Co Ltd has also experienced positive growth in global markets, reflecting its commitment to delivering high-quality medical products and services worldwide. Additionally, the company has introduced groundbreaking advancements in medical technology, improving patient care and revolutionizing the healthcare industry.

What is the history and background of the company Genertec Universal Medical Group Co?

Genertec Universal Medical Group Co Ltd is a diversified healthcare company based in China. Established in 2001, the company has since grown to become one of the leading providers of medical products and services in the country. With a strong focus on innovation and quality, Genertec Universal Medical Group has continuously expanded its product portfolio and developed strategic partnerships with global medical technology companies. The company's commitment to improving healthcare standards in China has earned it a solid reputation within the industry. With a comprehensive range of medical devices, pharmaceuticals, and healthcare solutions, Genertec Universal Medical Group continues to contribute to the advancement of healthcare in China and beyond.

Who are the main competitors of Genertec Universal Medical Group Co in the market?

The main competitors of Genertec Universal Medical Group Co Ltd in the market include Beijing Tiantan Hospital, China National Pharmaceutical Group Corporation, and China Resources (Holdings) Co Ltd.

In which industries is Genertec Universal Medical Group Co primarily active?

Genertec Universal Medical Group Co Ltd operates primarily in the healthcare and medical industry. With a focus on providing comprehensive medical services, the company offers a wide range of healthcare solutions including hospital management, medical equipment manufacturing, pharmaceutical research and development, and healthcare technology services. Genertec Universal Medical Group Co Ltd strives to contribute to the advancement of healthcare by delivering innovative and high-quality services to patients.

What is the business model of Genertec Universal Medical Group Co?

The business model of Genertec Universal Medical Group Co Ltd is focused on providing comprehensive medical solutions and services. With China as its core market, the company operates various business segments, including medical equipment and instrument manufacturing, medical technology research and development, medical service outsourcing, and medical investment and management. Genertec Universal Medical Group Co Ltd aims to leverage its expertise and resources to promote the development of China's medical industry, enhance healthcare services, and improve overall medical standards.

What is the P/E ratio of Genertec Universal Medical Group Co 2024?

The Genertec Universal Medical Group Co P/E ratio is 4.52.

What is the P/S ratio of Genertec Universal Medical Group Co 2024?

The Genertec Universal Medical Group Co P/S ratio is 0.64.

What is the Quality Investing of Genertec Universal Medical Group Co?

The Quality Investing for Genertec Universal Medical Group Co is 6/10.

What is the revenue of Genertec Universal Medical Group Co 2024?

The expected Genertec Universal Medical Group Co revenue is 14.58 B CNY.

How high is the profit of Genertec Universal Medical Group Co 2024?

The expected Genertec Universal Medical Group Co profit is 2.08 B CNY.

What is the business model of Genertec Universal Medical Group Co

The company Genertec Universal Medical Group Co Ltd (GUMG) is an internationally operating company in the healthcare sector. It was founded in 2001 as a subsidiary of Genertec Holding Co Ltd, one of the leading Chinese energy companies. GUMG's business model is to offer comprehensive healthcare services that encompass all aspects of the healthcare industry. The company consists of various divisions, all contributing to the overall strategy of the healthcare company in different ways. One of GUMG's most important divisions is the hospital group. The company operates multiple hospitals in China and strives to provide high-quality medical services at the highest level. The hospitals offer specialized treatments for cancer patients, cardiovascular diseases, as well as neurology and orthopedics. Another important area of GUMG is research and development. The company has been investing in the research of new drugs and treatment methods for years, collaborating closely with renowned universities and research institutions in China. GUMG has already achieved several significant medical breakthroughs and continues its research activities to further improve healthcare in the future. In addition to hospitals and research, GUMG also heavily invests in the development of medical devices and technologies. The company operates its own research and development team that develops innovative products and brings them to the international market. Some of the products offered by GUMG include ultrasound devices, endoscopy equipment, EKG systems, and other medical instruments. Lastly, GUMG is also heavily involved in the training of medical professionals. The company operates its own training facilities and advocates for the improvement of medical education in China and other countries. GUMG aims to educate a new generation of physicians who are equipped to meet the challenges of modern healthcare. In summary, GUMG's business model is focused on providing comprehensive healthcare services. The company operates hospitals, conducts research and develops new medical products and technologies, and engages in the training of medical professionals. GUMG collaborates closely with universities and research institutions and strives to improve healthcare worldwide.

What is the Genertec Universal Medical Group Co dividend?

Genertec Universal Medical Group Co pays a dividend of 0.36 CNY distributed over payouts per year.

How often does Genertec Universal Medical Group Co pay dividends?

The dividend cannot currently be calculated for Genertec Universal Medical Group Co or the company does not pay out a dividend.

What is the Genertec Universal Medical Group Co ISIN?

The ISIN of Genertec Universal Medical Group Co is HK0000255361.

What is the Genertec Universal Medical Group Co WKN?

The WKN of Genertec Universal Medical Group Co is A14V3L.

What is the Genertec Universal Medical Group Co ticker?

The ticker of Genertec Universal Medical Group Co is 2666.HK.

How much dividend does Genertec Universal Medical Group Co pay?

Over the past 12 months, Genertec Universal Medical Group Co paid a dividend of 0.34 CNY . This corresponds to a dividend yield of about 7.55 %. For the coming 12 months, Genertec Universal Medical Group Co is expected to pay a dividend of 0.37 CNY.

What is the dividend yield of Genertec Universal Medical Group Co?

The current dividend yield of Genertec Universal Medical Group Co is 7.55 %.

When does Genertec Universal Medical Group Co pay dividends?

Genertec Universal Medical Group Co pays a quarterly dividend. This is distributed in the months of July, July, July, July.

How secure is the dividend of Genertec Universal Medical Group Co?

Genertec Universal Medical Group Co paid dividends every year for the past 11 years.

What is the dividend of Genertec Universal Medical Group Co?

For the upcoming 12 months, dividends amounting to 0.37 CNY are expected. This corresponds to a dividend yield of 8.13 %.

In which sector is Genertec Universal Medical Group Co located?

Genertec Universal Medical Group Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Genertec Universal Medical Group Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Genertec Universal Medical Group Co from 7/30/2024 amounting to 0.04 CNY, you needed to have the stock in your portfolio before the ex-date on 6/14/2024.

When did Genertec Universal Medical Group Co pay the last dividend?

The last dividend was paid out on 7/30/2024.

What was the dividend of Genertec Universal Medical Group Co in the year 2023?

In the year 2023, Genertec Universal Medical Group Co distributed 0.36 CNY as dividends.

In which currency does Genertec Universal Medical Group Co pay out the dividend?

The dividends of Genertec Universal Medical Group Co are distributed in CNY.

Stock Exchange	Genertec Universal Medical Group Co Ticker
FRANKFURT	5UM.F
HKSE	2666.HK
PNK	UMTAF

Genertec Universal Medical Group Co Ticker	Genertec Universal Medical Group Co FIGI
2666:HK	BBG009GTNRW9
5UM:GR	BBG009L20D03
5UM:GF	BBG009L20D12
5UM:GB	BBG009L20D67
5UM:TH	BBG009PH7409
2666EUR:EO	BBG00CX447F2
2666EUR:XH	BBG00CX447J8
2666EUR:XF	BBG00CX447L5
2666EUR:XE	BBG00CX447N3
2666EUR:XJ	BBG00CX447P1
2666EUR:XL	BBG00CX447Q0
2666EUR:XG	BBG00CX447R9
2666EUR:XO	BBG00CX447S8
2666EUR:XS	BBG00CX447X2
2666EUR:XA	BBG00CX447Y1
2666EUR:E1	BBG00CX447Z0
2666EUR:XT	BBG00CX44806
2666EUR:XW	BBG00CX44815
2666EUR:XU	BBG00CX44824
2666EUR:XV	BBG00CX44833
2666EUR:EU	BBG00CX44851
2666:H2	BBG00F135W75
UMTAF:US	BBG00HCYS0F7
UMTAF:PQ	BBG00HCYS0T2
UMTAF:UV	BBG00HCYS0V9
2666EUR:XX	BBG00JN8HK39
2666N:PO	BBG00JRF9B01
2666N:L3	BBG00JRFD7Z7
2666N:B3	BBG00JRFG1C2
2666HKD:X2	BBG00JRGDBP7
2666HKD:XB	BBG00JRGDBQ6
2666HKD:XH	BBG00JRGDBS4
2666HKD:XF	BBG00JRGDBV0
2666HKD:XE	BBG00JRGDBX8
2666HKD:XJ	BBG00JRGDBY7
2666HKD:XL	BBG00JRGDBZ6
2666HKD:XG	BBG00JRGDC02
2666HKD:XO	BBG00JRGDC11
2666HKD:XS	BBG00JRGDC57
2666HKD:XA	BBG00JRGDC66
2666HKD:E1	BBG00JRGDC75
2666HKD:XT	BBG00JRGDC84
2666HKD:XW	BBG00JRGDC93
2666HKD:XU	BBG00JRGDCB0
2666HKD:XV	BBG00JRGDCC9
2666HKD:XM	BBG00JRGDCD8
2666HKD:XQ	BBG00JRGDCG5
2666HKD:XX	BBG00JRGDCH4
2666HKD:XZ	BBG00JRGDCJ2
2666HKD:EU	BBG00JRGDCL9
2666N:L1	BBG00Y7B1N56
5UM:LA	BBG018H9DY86
5UM:LU	BBG018J31Z14
2666:H1	BBG01FRSRB73
5UM:GZ	BBG01KH1Z781

Access the world's leading financial data and tools

Price

Price

Ticker2666.HK

ISINHK0000255361

WKNA14V3L

Genertec Universal Medical Group Co stock price

Price

Overview

Intraday Feature

Total Return and Relative Price Change

Interpretation and Investment

Genertec Universal Medical Group Co Stock Price History

Genertec Universal Medical Group Co Revenue, EBIT, Net Income HK0000255361 · A14V3L

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Yearly Analysis and Comparisons

Utilizing Expectations for Investment

Investment Insights

Genertec Universal Medical Group Co Revenue, EBIT and net profit per share

Genertec Universal Medical Group Co Income Statement, Balance Sheet, Cash Flow Statement

Keystats

Revenue and Growth

Gross Margin

EBIT and EBIT Margin

Income and Growth

Shares Outstanding

Interpreting Year to Year Comparison

Expectations and Predictions

Balance Sheet

Understanding the Balance Sheet

Assets

Liabilities

Equity

Year-to-Year Analysis

Interpreting the Data

Genertec Universal Medical Group Co stock margins HK0000255361 · A14V3L

Margin

Understanding Gross Margin

EBIT Margin Analysis

Revenue Margin Insights

Interpreting Expectations

Comparative Analysis

Genertec Universal Medical Group Co Margin History

Genertec Universal Medical Group Co Stock Sales Revenue, EBIT, Earnings per Share HK0000255361 · A14V3L

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Genertec Universal Medical Group Co Revenue, EBIT and net profit per share

Genertec Universal Medical Group Co business model

Genertec Universal Medical Group Co SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

The World’s Best Investors Are On Eulerpool

Genertec Universal Medical Group Co Eulerpool Fair Value

Fair Value

Understanding Fair Value

Income-Based Fair Value

Revenue-Based Fair Value

Dividend-Based Fair Value

Expectations and Forecasts

Comparative Analysis

Genertec Universal Medical Group Co historical P/E ratio, EBIT multiple, and P/S ratio

The World’s Best Investors Are On Eulerpool

Genertec Universal Medical Group Co shares outstanding HK0000255361 · A14V3L

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Genertec Universal Medical Group Co dividend history and estimates HK0000255361 · A14V3L

Dividend

Dividend Overview

Interpretation and Use

Investment Strategy

Genertec Universal Medical Group Co Dividend History

Ticker
2666.HK

ISIN
HK0000255361

WKN
A14V3L